plague vaccine
Vaccineapproved
Approved
May 14, 1942
Plague vaccine is a vaccine used against Yersinia pestis to prevent the plague. Inactivated bacterial vaccines have been used since 1890 but are less effective against the pneumonic plague, so live, attenuated vaccines and recombinant protein vaccines have been developed to prevent the disease. — Wikipedia
Clinical trial activity
2 trials · 2 clinical orgs · 1 marketing orgs
Phase 1
0
Phase 2
2
Phase 3
0
Phase 4
0
Earliest trial started Oct 1, 2014 (NCT02596308)
Timeline
1940s
- May 14, 1942
Earliest FDA Approval
1990s
- Oct 5, 1994
Greer Laboratories — First NDA Organization
- Oct 5, 1994
Greer Laboratories — NDA Secondary Org
- Oct 5, 1994
Greer Laboratories — NDA Organization
2010s
- Jan 1, 2014
Earliest Phase 2 Sponsor(trial)
Indications
Approved for
Studied for
Mechanism of action
- Unspecified targetOTHER
Biological vaccine - induces immune response
- Yersinia pestisImmunity, active
Yersinia pestis immunity, active
Approval history
- approvedMay 14, 1942
Chemistry & pharmacology
- Chirality
- Single Stereoisomer
- Inorganic
- No
- Polymer
- No
Oral
No
Parenteral
No
Topical
No
Sources
- WikipediaPlague vaccine ↗
- ChEMBLCHEMBL2107906 ↗
Also known as
- plague vaccine
- plague vaccine
- plague vaccine
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT05330624 | Phase 2 | May 8, 2020 | Government of China |
| NCT02596308 | Phase 2 | Oct 1, 2014 | China National Biotec Group Co., Ltd, Government of China |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (2)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Government of China | Government | 2 | 2 | 1 | 2014 |
| China National Biotec Group Co., Ltd | For profit | 1 | 0 | 1 | 2014 |
2 organizations
Page 1 / 1
Marketing (2)
| Organization | Org type | Relationship | Date |
|---|---|---|---|
| Greer Laboratories | For profit | NDA2 | Oct 5, 1994 |
| Greer Laboratories | For profit | NDA | Oct 5, 1994 |